Key facts
- President Trump is taking a hands-on approach to regulatory matters.
- His involvement extends to shaping mergers and influencing drug policy.
- This represents a departure from past presidential practices.
President Trump has adopted an unusually hands-on approach to regulatory oversight, positioning himself as the nation's chief regulator. This departure from historical presidential norms involves diving into specific policy details, including influencing merger approvals and weighing in on the regulation of psychedelic drugs. His direct involvement signifies a more interventionist stance compared to previous administrations, where such detailed regulatory shaping was less common at the presidential level.